Related references
Note: Only part of the references are listed.BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy
Christoph Oing et al.
CANCER LETTERS (2018)
Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
W. Y. Mansour et al.
SCIENTIFIC REPORTS (2018)
Ex vivo gamma H2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity
Chiara De-Colle et al.
RADIOTHERAPY AND ONCOLOGY (2017)
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells
Francesco Morra et al.
ONCOTARGET (2017)
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari et al.
EMBO REPORTS (2016)
DNA damage foci: Meaning and significance
Kai Rothkamm et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2015)
Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation
A. Bakr et al.
NUCLEIC ACIDS RESEARCH (2015)
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
Apostolos Menegakis et al.
RADIOTHERAPY AND ONCOLOGY (2015)
γH2AX assay in ex vivo irradiated tumour specimens: A novel Method to determine tumour radiation sensitivity in patient-derived material
Apostolos Menegakis et al.
RADIOTHERAPY AND ONCOLOGY (2015)
DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity
Henning Willers et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer
Tobias Lange et al.
CLINICAL CANCER RESEARCH (2014)
Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
Kishan A. T. Naipal et al.
CLINICAL CANCER RESEARCH (2014)
Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells
Annika Koetter et al.
MOLECULAR ONCOLOGY (2014)
The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining
Wael Y. Mansour et al.
DNA REPAIR (2013)
Poly(ADP-ribose)polymerases are involved in microhomology mediated back-up non-homologous end joining in Arabidopsis thaliana
Qi Jia et al.
PLANT MOLECULAR BIOLOGY (2013)
Residual γH2AX foci predict local tumour control after radiotherapy
Ulrike Koch et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
Tobias Lange et al.
CLINICAL CANCER RESEARCH (2012)
Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase
Sabrina Koecher et al.
NUCLEIC ACIDS RESEARCH (2012)
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
Christiane M. Robbins et al.
GENOME RESEARCH (2011)
Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
Joana M. Senra et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
C. Powell et al.
CANCER TREATMENT REVIEWS (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies
Wael Y. Mansour et al.
NUCLEIC ACIDS RESEARCH (2010)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Backup pathways of NHEJ in cells of higher eukaryotes: Cell cycle dependence
George Iliakis
RADIOTHERAPY AND ONCOLOGY (2009)
Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy
Kersthin Borgmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks
Wael Y. Mansour et al.
NUCLEIC ACIDS RESEARCH (2008)
DNA double-strand break repair: From mechanistic understanding to cancer treatment
Thomas Helleday et al.
DNA REPAIR (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
DNA ligase III as a candidate component of backup pathways of nonhomologous end joining
HC Wang et al.
CANCER RESEARCH (2005)
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
M Audebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hippocampal synapses depend on hippocampal estrogen synthesis
O Kretz et al.
JOURNAL OF NEUROSCIENCE (2004)
Pathways of DNA double-strand break repair during the mammalian cell cycle
K Rothkamm et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining
E Feldmann et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
